- Home
- IDE vs HRTX Comparison
IDE vs HRTX Comparison
Compare IDE & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDE
- HRTX
- Stock Information
- Founded
- IDE 2010
- HRTX 1983
- Country
- IDE United States
- HRTX United States
- Employees
- IDE N/A
- HRTX N/A
- Industry
- IDE Finance/Investors Services
- HRTX Biotechnology: Pharmaceutical Preparations
- Sector
- IDE Finance
- HRTX Health Care
- Exchange
- IDE Nasdaq
- HRTX Nasdaq
- Market Cap
- IDE 186.0M
- HRTX 214.5M
- IPO Year
- IDE N/A
- HRTX 1987
- Fundamental
- Price
- IDE $12.37
- HRTX $1.20
- Analyst Decision
- IDE
- HRTX Strong Buy
- Analyst Count
- IDE 0
- HRTX 2
- Target Price
- IDE N/A
- HRTX $4.50
- AVG Volume (30 Days)
- IDE 33.5K
- HRTX 1.5M
- Earning Date
- IDE 01-01-0001
- HRTX 11-04-2025
- Dividend Yield
- IDE 8.83%
- HRTX N/A
- EPS Growth
- IDE N/A
- HRTX N/A
- EPS
- IDE N/A
- HRTX N/A
- Revenue
- IDE N/A
- HRTX $149,694,000.00
- Revenue This Year
- IDE N/A
- HRTX $10.62
- Revenue Next Year
- IDE N/A
- HRTX $12.99
- P/E Ratio
- IDE N/A
- HRTX N/A
- Revenue Growth
- IDE N/A
- HRTX 9.78
- 52 Week Low
- IDE $8.61
- HRTX $1.04
- 52 Week High
- IDE $10.46
- HRTX $2.68
- Technical
- Relative Strength Index (RSI)
- IDE 57.61
- HRTX 36.85
- Support Level
- IDE $12.18
- HRTX $1.16
- Resistance Level
- IDE $12.40
- HRTX $1.21
- Average True Range (ATR)
- IDE 0.14
- HRTX 0.06
- MACD
- IDE 0.03
- HRTX -0.01
- Stochastic Oscillator
- IDE 94.23
- HRTX 4.17
About IDE Voya Infrastructure Industrials and Materials Fund of Beneficial Interest
Voya Infrastructure, Industrials and Materials Fund is a diversified closed-end management investment company. The primary objective of this investment fund is to achieve total return by combining current income, capital gains, and capital appreciation. To achieve this objective, the fund invests in companies that own and/or operate infrastructure facilities in the infrastructure sector, as well as in a broad range of companies in the industrials and materials sectors that the Sub-Adviser believes will benefit from infrastructure building, renovation, expansion, and utilization.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.